RxDoctor Payments Data

George Thomas, MD

Family Medicine · Hayneville, ALNPI 1972526614

Payments from drug & device makers

$934in general payments, 2019–2025

Across 39 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$312
  • Zimmer Biomet$203
  • Ossur Americas, Inc.$71
  • Gilead$67
  • Boehringer Ingelheim$35
  • Exact Sciences$33
  • plus $213 from 10 others

What the payments were for

  • Food & beverage$934100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$934 in reported general payments places this provider in the 55th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$629
Medicare patients
39
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin63$74,175
EliquisApixaban66$66,999
FarxigaDapagliflozin Propanediol69$60,183
LinzessLinaclotide56$46,396
JanuviaSitagliptin Phosphate24$38,689
OzempicSemaglutide20$32,640
MounjaroTirzepatide17$24,041
EntrestoSacubitril/Valsartan14$16,377
RybelsusSemaglutide12$13,630
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,580
XareltoRivaroxaban12$11,523
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$9,195
LantusInsulin Glargine,hum.Rec.Anlog35$4,338
Rosuvastatin Calcium238$4,193
Famotidine98$3,692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$35$74,17563 claims
PfizerEliquis$312$66,99966 claims
AstraZenecaFarxiga, Symbicort$26$62,94681 claims
AbbVieLinzess$28$46,39656 claims
Novo NordiskOzempic, Rybelsus$15$46,27032 claims
GSKTrelegy Ellipta$21$12,58019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Hayneville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →